Javascript must be enabled to continue!
Abstract P498: Polycystin-1 Regulates Excitation-contraction Coupling In Atrial Cardiomyocytes
View through CrossRef
Patients with Autosomal Dominant Polycystic Kidney disease (ADPKD) have multiple cardiovascular manifestations, including increased susceptibility to arrhythmias. Mutations in polycystin-1 (PC1) encoding gene accounts for 85% cases of ADPKD, whereas mutations in polycystin-2 (PC2) only accounts for 15%. In kidney cells, PC1 interacts with PC2 to form a protein complex at the primary cilia to regulate calcium influx via PC2. However, cardiomyocytes are non-ciliated cells and the role of both PC1 and PC2 in atrial cardiomyocytes remains unknown. We have previously demonstrated that PC1 regulates action potentials and calcium handling to fine-tune ventricular cardiomyocyte contraction. Here, we hypothesize that PC1 regulates action potentials and calcium handling in atrial cardiomyocytes independent of PC2 actions. To test this hypothesis, we differentiated human induced pluripotent stem cells (iPSC) into atrial cardiomyocytes (iPSC-aCM) using previously published protocols. To determine the contribution of PC1/PC2 in atrial excitation-contraction coupling, protein expression was knocked down utilizing specific siRNA constructs, for each protein, or a universal control siRNA transfected using lipofectamine RNAiMAX. We measured action potentials using the potentiometric dye FluoVolt and intracellular calcium with Fura-2 AM or Fluo-4. Changes in fluorescence were monitored using a multiwavelength IonOptix system. iPSC-aCM were paced at 2 Hz to synchronize the beating pattern using field electrical stimulation. Our data shows that PC1 ablation significantly decreased action potential duration at 50% and 80% of repolarization, by 24% and 23%, respectively. Moreover, we observed that PC1 knockdown significantly reduced calcium transient amplitude elicited by field electrical stimulation without changes in calcium transient decay. Interestingly, PC2 knockdown did not modify calcium transients in atrial cardiomyocytes (iPSC-aCM). Our data suggest that PC1 regulates atrial excitation-contraction coupling independent of PC2 actions. This study warrants further investigation into atrial dysfunction in ADPKD patients with PC1 mutations.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract P498: Polycystin-1 Regulates Excitation-contraction Coupling In Atrial Cardiomyocytes
Description:
Patients with Autosomal Dominant Polycystic Kidney disease (ADPKD) have multiple cardiovascular manifestations, including increased susceptibility to arrhythmias.
Mutations in polycystin-1 (PC1) encoding gene accounts for 85% cases of ADPKD, whereas mutations in polycystin-2 (PC2) only accounts for 15%.
In kidney cells, PC1 interacts with PC2 to form a protein complex at the primary cilia to regulate calcium influx via PC2.
However, cardiomyocytes are non-ciliated cells and the role of both PC1 and PC2 in atrial cardiomyocytes remains unknown.
We have previously demonstrated that PC1 regulates action potentials and calcium handling to fine-tune ventricular cardiomyocyte contraction.
Here, we hypothesize that PC1 regulates action potentials and calcium handling in atrial cardiomyocytes independent of PC2 actions.
To test this hypothesis, we differentiated human induced pluripotent stem cells (iPSC) into atrial cardiomyocytes (iPSC-aCM) using previously published protocols.
To determine the contribution of PC1/PC2 in atrial excitation-contraction coupling, protein expression was knocked down utilizing specific siRNA constructs, for each protein, or a universal control siRNA transfected using lipofectamine RNAiMAX.
We measured action potentials using the potentiometric dye FluoVolt and intracellular calcium with Fura-2 AM or Fluo-4.
Changes in fluorescence were monitored using a multiwavelength IonOptix system.
iPSC-aCM were paced at 2 Hz to synchronize the beating pattern using field electrical stimulation.
Our data shows that PC1 ablation significantly decreased action potential duration at 50% and 80% of repolarization, by 24% and 23%, respectively.
Moreover, we observed that PC1 knockdown significantly reduced calcium transient amplitude elicited by field electrical stimulation without changes in calcium transient decay.
Interestingly, PC2 knockdown did not modify calcium transients in atrial cardiomyocytes (iPSC-aCM).
Our data suggest that PC1 regulates atrial excitation-contraction coupling independent of PC2 actions.
This study warrants further investigation into atrial dysfunction in ADPKD patients with PC1 mutations.
Related Results
Polycystin-1 loss of function increases susceptibility to atrial fibrillation through impaired DNA damage response
Polycystin-1 loss of function increases susceptibility to atrial fibrillation through impaired DNA damage response
Background: The increasing prevalence of atrial fibrillation (AF) and chronic kidney diseases highlights the need for a deeper comprehension of the molecular mechanisms linking the...
ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
ASSA13-03-40 The Study of Cardiomyocytes Gene Modified by Recombinant Adeno-Associated Virus-9 Combined with PDGF-B in Vitro
Objective
To explore the feasibility, safety and anti-apoptosis of using recombinant adeno-associated virus-9 which contained platelet-derived growth factor-B (rA...
Inter‐Relationships Between Atrial Flutter and Atrial Fibrillation
Inter‐Relationships Between Atrial Flutter and Atrial Fibrillation
It has been appreciated for a long time that atrial flutter and atrial fibrillation have a clinical relationship. Now, with the technological advances that permit more sophisticate...
Left atrial appendage anatomy and function: short term response to sustained atrial fibrillation
Left atrial appendage anatomy and function: short term response to sustained atrial fibrillation
OBJECTIVE
To determine whether there is significant atrial or atrial appendage enlargement or functional remodelling as a result of one to two months of sustained...
P920Understanding arrhythmia mechanisms in patients with atrial septal defects
P920Understanding arrhythmia mechanisms in patients with atrial septal defects
Abstract
Background
Atrial arrhythmias represent a major cause of morbidity and hospitalization in patients with atrial septal d...
Case report: Para Hisian Atrial Tachycardia
Case report: Para Hisian Atrial Tachycardia
Atrial tachycardia accounts for around 10% of supraventricular tachycardias (1). Atrial tachycardia can either be focal or macrorenentrant. Focal AT usually start at a focal p...
Left atrial function assessment by speckle tracking echocardiography in low-risk atrial fibrillation patients
Left atrial function assessment by speckle tracking echocardiography in low-risk atrial fibrillation patients
Objective: To compare the left atrial function utilising speckle tracking echocardiography in patients with low-risk and high-risk non-valvular atrial fibrillation.Methods: The des...
Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation
Galectin-3 Induces Atrial Fibrosis by Activating the TGF-β1/Smad Pathway in Patients with Atrial Fibrillation
<b><i>Background:</i></b> Atrial fibrosis plays a critical role in the occurrence and maintenance of atrial fibrillation. The role of TGF-β1 in mediating at...

